Immuron (IMRN) Work In Process (2017 - 2020)

Immuron (IMRN) posted quarterly Work In Process of $8620.0 for Q4 2020, down 88.81% quarter-over-quarter from $77061.7 in Q2 2020.

Immuron (IMRN) Work In Process (2017 - 2020) Analysis & Trends

Immuron's Work In Process history runs 4 years deep, the most recent figure standing at $8620.0 for Q4 2020.

In Q4 2020, Work In Process changed N/A year-over-year to $8620.0; the TTM figure through Dec 2020 stood at $8620.0 (changed N/A YoY), while the FY2020 annual figure was $8620.0, changed N/A from the prior year.
Work In Process for Q4 2020 stood at $8620.0, down from $77061.7 in the prior quarter.
The five-year high for Work In Process was $134770.2 in Q2 2019, with the low at $8620.0 in Q4 2020.
The 4-year median for Work In Process is $35001.2 (2018), against an average of $52651.6.
The sharpest annual moves came in 2019 and 2020: Work In Process surged 429.44% in 2019, then plunged 42.82% in 2020.
Immuron's Work In Process stood at $36377.4 in 2017, then retreated by 7.57% to $33625.0 in 2018, then soared by 300.8% to $134770.2 in 2019, then plunged by 93.6% to $8620.0 in 2020.
Business Quant data shows IMRN's Work In Process at $8620.0 in Q4 2020, $77061.7 in Q2 2020, and $134770.2 in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Immuron	6.75 Mn	6.73 Mn	-

Download Data